V Hird

1.5k total citations
19 papers, 979 citations indexed

About

V Hird is a scholar working on Radiology, Nuclear Medicine and Imaging, Reproductive Medicine and Epidemiology. According to data from OpenAlex, V Hird has authored 19 papers receiving a total of 979 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Reproductive Medicine and 6 papers in Epidemiology. Recurrent topics in V Hird's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). V Hird is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Ovarian cancer diagnosis and treatment (6 papers). V Hird collaborates with scholars based in United Kingdom, United States and Egypt. V Hird's co-authors include M.H.F. Sullivan, John S. Stewart, H Lambert, Agamemnon A. Epenetos, D Snook, Gregory Sivolapenko, A. A. Epenetos, P. R. Mason, Anthony Maraveyas and M J Myers and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

V Hird

19 papers receiving 947 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V Hird United Kingdom	16	618	249	203	186	179	19	979
M. Granowska United Kingdom	20	935 1.5×	274 1.1×	177 0.9×	297 1.6×	181 1.0×	68	1.3k
G. Hooker United Kingdom	13	663 1.1×	228 0.9×	91 0.4×	178 1.0×	126 0.7×	17	847
V. Heilmann Germany	15	209 0.3×	342 1.4×	81 0.4×	200 1.1×	109 0.6×	32	870
Debra B. Novotny United States	17	185 0.3×	277 1.1×	308 1.5×	357 1.9×	274 1.5×	30	1.6k
Delicia Carey United States	15	221 0.4×	596 2.4×	113 0.6×	491 2.6×	139 0.8×	21	1.2k
Rob A. Verstraeten Netherlands	19	170 0.3×	184 0.7×	336 1.7×	319 1.7×	157 0.9×	32	838
Sidney Bennett United States	17	1.0k 1.6×	424 1.7×	84 0.4×	424 2.3×	165 0.9×	24	1.4k
Judith Jo Spain	15	250 0.4×	508 2.0×	82 0.4×	308 1.7×	46 0.3×	23	852
G Boxer United Kingdom	20	579 0.9×	309 1.2×	49 0.2×	563 3.0×	109 0.6×	41	1.2k
Isabelle Navarro‐Teulon France	21	851 1.4×	410 1.6×	101 0.5×	416 2.2×	223 1.2×	42	1.3k

Countries citing papers authored by V Hird

Since Specialization

Citations

This map shows the geographic impact of V Hird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V Hird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V Hird more than expected).

Fields of papers citing papers by V Hird

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V Hird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V Hird. The network helps show where V Hird may publish in the future.

Co-authorship network of co-authors of V Hird

This figure shows the co-authorship network connecting the top 25 collaborators of V Hird. A scholar is included among the top collaborators of V Hird based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V Hird. V Hird is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Stemke‐Hale, Katherine, David González de Castro, V Hird, et al.. (2012). Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes. Modern Pathology. 26(4). 544–552. 17 indexed citations

Saso, Srdjan, Sadaf Ghaem‐Maghami, Jayanta Chatterjee, et al.. (2011). Abdominal radical trachelectomy in West London. BJOG An International Journal of Obstetrics & Gynaecology. 119(2). 187–193. 38 indexed citations

Soutter, William P., Emmanuel Diakomanolis, Deirdre Lyons, et al.. (2009). Dynamic Spectral Imaging: Improving Colposcopy. Clinical Cancer Research. 15(5). 1814–1820. 57 indexed citations

Epenetos, Agamemnon A., et al.. (2000). Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy. International Journal of Gynecological Cancer. 10(s1). 44–46. 69 indexed citations

Nicholson, Steve, V Hird, Anthony Maraveyas, et al.. (1998). Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis.. Oncology Reports. 5(1). 223–6. 62 indexed citations

Kalofonos, Haralabos P., Christos Kosmas, V Hird, D Snook, & A. A. Epenetos. (1994). Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: Immunolocalisation, pharmacokinetics and immune response. European Journal of Cancer. 30(12). 1842–1850. 9 indexed citations

Maraveyas, Anthony, et al.. (1994). Pharmacokinetics and toxicity of an yttrium‐90‐citc‐dtpa‐hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer. Cancer. 73(S3). 1067–1075. 38 indexed citations

Hird, V, Anthony Maraveyas, D Snook, et al.. (1993). Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. British Journal of Cancer. 68(2). 403–406. 132 indexed citations

Hird, V, Martine Verhoeyen, R.A. Badley, et al.. (1991). Tumour localisation with a radioactively labelled reshaped human monoclonal antibody. British Journal of Cancer. 64(5). 911–914. 33 indexed citations

10.

Hird, V, et al.. (1990). Intraperitoneal radioimmunotherapy for ovarian cancer. International Journal of Gynecology & Obstetrics. 31(1). 96–96. 4 indexed citations

11.

Stewart, John S., V Hird, D Snook, et al.. (1990). Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.. Journal of Clinical Oncology. 8(12). 1941–1950. 102 indexed citations

12.

Hird, V, et al.. (1990). c‐erbB‐2 oncogene expression in ovarian cancer. The Journal of Pathology. 162(3). 231–237. 75 indexed citations

13.

Davies, Kelvin J.A., V Hird, Shelley Stewart, et al.. (1990). A study of in vivo immune complex formation and clearance in man.. The Journal of Immunology. 144(12). 4613–4620. 88 indexed citations

14.

Stewart, John S., Gregory Sivolapenko, V Hird, et al.. (1990). Clearance of 131I-labeled murine monoclonal antibody from patients' blood by intravenous human anti-murine immunoglobulin antibody.. PubMed. 50(3). 563–7. 16 indexed citations

15.

Stewart, John S., V Hird, M.H.F. Sullivan, D Snook, & A. A. Epenetos. (1989). Intraperitoneal radioimmunotherapy for ovarian cancer. BJOG An International Journal of Obstetrics & Gynaecology. 96(5). 529–536. 39 indexed citations

16.

Stewart, J.S.W., V Hird, D Snook, et al.. (1989). Intraperitoneal radioimmunotherapy for ovarian cancer: Pharmacokinetics, toxicity, and efficacy of I-131 labeled monoclonal antibodies. International Journal of Radiation Oncology*Biology*Physics. 16(2). 405–413. 88 indexed citations

17.

Hird, V, H. Thomas, John S. Stewart, & Agamemnon A. Epenetos. (1989). Malignant ascites: review of the literature, and an update on monoclonal antibody-targeted therapy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 32(1). 37–45. 13 indexed citations

18.

Stewart, John S., V Hird, D Snook, et al.. (1988). Intraperitoneal131I- and90-labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetry. International Journal of Cancer. 41(S3). 71–76. 46 indexed citations

19.

Stewart, John S., V Hird, D Snook, et al.. (1988). Intraperitoneal 131I- and 90Y-labelled monoclonal antibodies for ovarian cancer: pharmacokinetics and normal tissue dosimetry.. PubMed. 3. 71–6. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact